BioPharma Credit PLC
BOPCF
$0.96
$0.011.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 157.75M | 156.21M | 154.66M | 152.35M | 150.03M |
| Total Revenue | 157.75M | 156.21M | 154.66M | 152.35M | 150.03M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 157.75M | 156.21M | 154.66M | 152.35M | 150.03M |
| SG&A Expenses | 28.03M | 29.84M | 31.65M | 29.68M | 27.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -135.00K | -109.00K | -83.00K | 23.50K | 130.00K |
| Total Operating Expenses | 27.90M | 29.73M | 31.56M | 29.71M | 27.85M |
| Operating Income | 129.85M | 126.48M | 123.10M | 122.64M | 122.18M |
| Income Before Tax | 129.89M | 126.51M | 123.12M | 122.65M | 122.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 129.89 | 126.51 | 123.12 | 122.65 | 122.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 129.89M | 126.51M | 123.12M | 122.65M | 122.18M |
| EBIT | 129.85M | 126.48M | 123.10M | 122.64M | 122.18M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.11 | 0.11 | 0.11 | 0.10 | 0.10 |
| Normalized Basic EPS | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 |
| EPS Diluted | 0.11 | 0.11 | 0.11 | 0.10 | 0.10 |
| Normalized Diluted EPS | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 |
| Average Basic Shares Outstanding | 4.56B | 4.63B | 4.70B | 4.79B | 4.89B |
| Average Diluted Shares Outstanding | 4.56B | 4.63B | 4.70B | 4.79B | 4.89B |
| Dividend Per Share | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Payout Ratio | 61.56% | 53.99% | 46.01% | 67.54% | 89.23% |